Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality i...
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited heart disease encumbered throughout much of its almost 60-year history by the expectation of an unfavorable outcome with shortened longevity. However, it is notable that in 2023, most patients affected with HCM can now achieve normal or extended life expectancy without major d...
Alternative Titles
Full title
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2928251156
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2928251156
Other Identifiers
ISSN
0002-9149,1879-1913
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2023.10.073
